David M. Witcombe

Level 15, 151 Clarence Street
Sydney, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

The epidemiology, management, and the associated burden of migraine in Australian primary care: a retrospective analysis of electronic health record data.

The epidemiology, management, and the associated burden of migraine in Australian primary care: a retrospective analysis of electronic health record data.

Journal: The journal of headache and pain

Published: March 30, 2025

Psychosocial and Occupational Burden on Caregivers of Adolescents With Alopecia Areata in Australia.

Psychosocial and Occupational Burden on Caregivers of Adolescents With Alopecia Areata in Australia.

Journal: The Australasian journal of dermatology

Published: December 18, 2024

Estimated Incidence of Hospitalisations and Deaths Attributable to Respiratory Syncytial Virus Infections in Adults in Australia Between 2010 and 2019.

Estimated Incidence of Hospitalisations and Deaths Attributable to Respiratory Syncytial Virus Infections in Adults in Australia Between 2010 and 2019.

Journal: Influenza and other respiratory viruses

Published: November 22, 2024

Health-related quality of life of adult and adolescent patients living with alopecia areata in Australia.

Health-related quality of life of adult and adolescent patients living with alopecia areata in Australia.

Journal: The Australasian journal of dermatology

Published: April 09, 2024

Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia.

Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia.

Journal: Clinical rheumatology

Published: November 23, 2023

Incidence and prevalence of alopecia areata in the Australian primary care setting: A retrospective analysis of electronic health record data.

Incidence and prevalence of alopecia areata in the Australian primary care setting: A retrospective analysis of electronic health record data.

Journal: The Australasian journal of dermatology

Published: March 27, 2023

Real-world evaluation of effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis in Australia.

Real-world evaluation of effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis in Australia.

Journal: Clinical rheumatology

Published: May 19, 2021

Patient Perceptions of Psoriatic Arthritis Management and Communication with Physicians in Australia: Results from a Patient Survey.

Patient Perceptions of Psoriatic Arthritis Management and Communication with Physicians in Australia: Results from a Patient Survey.

Journal: Rheumatology and therapy

Published: December 17, 2020

Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in Australia.

Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in Australia.

Journal: Clinical rheumatology

Published: December 15, 2019

Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib.

Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib.

Journal: RMD open

Published: June 14, 2018

Tofacitinib 5 mg Twice Daily in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs: A Comprehensive Review of Phase 3 Efficacy and Safety.

Tofacitinib 5 mg Twice Daily in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs: A Comprehensive Review of Phase 3 Efficacy and Safety.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Published: May 26, 2018

Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population.

Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population.

Journal: Rheumatology and therapy

Published: March 18, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026